Hapbee (HAPB) Soars 136% the First Day of Trading!
LIVE QUOTE
Subscribe here for upcoming report.
Telehealth App Hapbee (HAPB) Goes Public and More.
1. Hapbee (HAPB) $0.30, Going Public.2. Saying Goodbye to Immunomedics (IMMU) $86.3. Adding Biosig (BSGM) $2.95, to Watch...
Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.
VANCOUVER, BC, Oct. 28, 2020 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) ("Hapbee" or the "Company"), a wellness technology company developing the...
Dalrada’s ‘VIA’ Test Screening Kit Goes Head to Head with ‘Pap’ Smear Test Screening.
DALRADA aims to introduce its VIA Test kit to females in India - of which there is 497 million.
Adding Telehealth Play CB Scientific (CBSC) $1.10 to CoronaVirus Watch List.
MyCardia's My-Cam Offers At-Home Heart Rate Monitoring.
LIVE QUOTE
Telehealth: CB Scientific (CBSC) Acquires Prevent Health Care International Corp.
CB Scientific, Inc. (CBSC) Announces Completion of Asset Purchase Agreement and Commencement of Its ECG Monitoring Business.
Video: Hapbee Testimonials.
Hapbee is powered by patented ultra-low radio frequency energy (ulRFE®) technology invented by...
Telehealth: How the Pandemic Forced Mental Health Care to Change for the Better (Vox).
New therapy options were desperately needed before the pandemic
Two facts overshadow all discussions of mental health care...
Mitesco Inc. Initiates “The Good Clinic” Rollout in Minneapolis; Introduces the Founders of “The...
MINNEAPOLIS, MN, Sept. 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Mitesco, Inc. (OTCQB: MITI) today announced that The Good Clinic, LLC has filed...
Peleton (PTON) Hits $25 Billion Valuation. Calm (Private) Hits Unicorn Valuation at $1 Billion.
Home Fitness and Wellness Raging on Main Street and Wall Street.
While 24 Hour Fitness Files for Bankruptcy..
Latest article
Asia-Pacific: A Region of Stability Amidst Economic Uncertainty
Contrary to the Western markets, there is a growing consensus that the Asia Pacific is emerging as a relatively safe harbour in...
Hepion (HEPA) Back in the Spotlight, Gains 230% in May.
Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and...
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating...
A pre-clinical observational study published in Drug Development & Delivery found that more than 80% of patients experienced relief within minutes of...
